Exchange: NASDAQ·Updated 08:02 PM EDT

TIVC News

News
all
press releases
Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening
Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.read more...
Benzinga
Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening
Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.read more...
Benzinga
More News
Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model...
PR Newswire
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Sheryle Bolton acquired 10,000 shares of Tivic Health Systems stock in a transaction on Wednesday, April 15th. The shares were...
MarketBeat
Tivic Health Selected to Present Entolimod as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th Tivic Health Selected to...
PR Newswire
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Christina Rizopoulos Valauri purchased 19,000 shares of Tivic Health Systems stock in a transaction dated Wednesday, April 1st. The shares were purchased at an average cost of $0.95 per share, for a total transaction of $18,050.00...
MarketBeat
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced it is expanding its intellectual property portfolio with the recent filing of two additional patent...
Business Wire
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and...
Business Wire
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global...
Business Wire
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...
Business Wire
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...
Business Wire

Advertisement|Remove ads.